MTOR and acute lymphoblastic leukemia: Moreover, in T-cell acute lymphoblastic leukaemia (T-ALL), the dual-specificity of PI3K/mTORi PKI-587 was the most selective for T-ALL cells dependent on the PI3K/mTOR pathway [103].